Smith & Nephew SNATS (NYSE:SNN) Cut to “Buy” at Wall Street Zen

Wall Street Zen lowered shares of Smith & Nephew SNATS (NYSE:SNN) from a strong-buy rating to a buy rating in a research note released on Saturday morning.

Several other analysts have also recently commented on SNN. Canaccord Genuity Group dropped their price target on Smith & Nephew SNATS from $36.00 to $34.00 and set a “hold” rating for the company in a research report on Tuesday, November 11th. Kepler Capital Markets raised shares of Smith & Nephew SNATS to a “strong-buy” rating in a research note on Monday, November 17th. Royal Bank Of Canada reaffirmed an “outperform” rating on shares of Smith & Nephew SNATS in a report on Monday, October 20th. Sanford C. Bernstein set a $37.50 price target on shares of Smith & Nephew SNATS and gave the stock a “market perform” rating in a research note on Tuesday, October 14th. Finally, Weiss Ratings restated a “hold (c+)” rating on shares of Smith & Nephew SNATS in a research report on Wednesday, October 8th. One investment analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and six have assigned a Hold rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $35.75.

Smith & Nephew SNATS Price Performance

NYSE:SNN opened at $33.47 on Friday. Smith & Nephew SNATS has a 12 month low of $23.69 and a 12 month high of $38.79. The stock has a 50 day moving average of $34.71 and a two-hundred day moving average of $33.59. The company has a current ratio of 3.00, a quick ratio of 1.40 and a debt-to-equity ratio of 0.60.

Hedge Funds Weigh In On Smith & Nephew SNATS

Several hedge funds and other institutional investors have recently made changes to their positions in SNN. Caitong International Asset Management Co. Ltd acquired a new stake in Smith & Nephew SNATS in the third quarter valued at $41,000. AlphaCore Capital LLC purchased a new position in Smith & Nephew SNATS during the 2nd quarter worth approximately $44,000. Northwestern Mutual Wealth Management Co. raised its position in Smith & Nephew SNATS by 105.8% in the 3rd quarter. Northwestern Mutual Wealth Management Co. now owns 1,385 shares of the medical equipment provider’s stock valued at $50,000 after purchasing an additional 712 shares during the last quarter. Huntington National Bank boosted its stake in shares of Smith & Nephew SNATS by 1,837.0% during the third quarter. Huntington National Bank now owns 1,414 shares of the medical equipment provider’s stock worth $51,000 after buying an additional 1,341 shares during the period. Finally, Banque Transatlantique SA purchased a new position in shares of Smith & Nephew SNATS in the 1st quarter valued at approximately $52,000. Hedge funds and other institutional investors own 25.64% of the company’s stock.

About Smith & Nephew SNATS

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT.